Disability News and Research

RSS

New award to recognize contributions linking neuroscience to psychiatric diagnosis and treatment

Mental health is in crisis worldwide. While the neurosciences are advancing rapidly, psychiatry still struggles to diagnose and effectively treat many disorders. The Synapsy Center for Neuroscience and Mental Health Research at the University of Geneva, Switzerland, is launching a new international prize to reward those who bring these two worlds closer together.

9 Apr 2025

Tolebrutinib shows promise for treating non-relapsing secondary progressive multiple sclerosis

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, demonstrated a 31% delay in the onset of six-month confirmed disability progression (CDP) in patients with non-relapsing secondary progressive multiple sclerosis (SPMS).

8 Apr 2025

Study reveals socioeconomic inequalities in unmet needs for mental health care across the EU

A new study presented today at the European Psychiatric Association Congress 2025 reveals significant socioeconomic inequalities in unmet needs for mental health care across European Union countries, with financial barriers disproportionately affecting lower-income populations.

7 Apr 2025

Mindfulness and CBT provide long-term relief for chronic back pain

The list of treatments for low back pain is endless, but few offer relief for the one in four Americans who suffer from this persistent pain and leading cause of disability globally. More than 80% of those with chronic low back pain wished there were better treatment options.

7 Apr 2025

Predicting treatment failure in cutaneous leishmaniasis with precision medicine

Nearly one million people worldwide are plagued annually by cutaneous leishmaniasis, a devastating skin infection caused by the Leishmania parasite.

7 Apr 2025

AI tool helps track treatment progress in multiple sclerosis patients

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers.

7 Apr 2025

The House Speaker’s eyeing big cuts to Medicaid. In his Louisiana district, It’s a lifeline.

When Desoto Regional Health System took out $36 million in loans last year to renovate a rural hospital that opened in 1952, officials were banking on its main funding source remaining stable: Medicaid, the joint federal-state health program for low-income people and the disabled.

7 Apr 2025

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Dr. Pascale Allotey advocates for comprehensive maternal health policies, stressing the importance of women's voices in shaping effective healthcare solutions.

7 Apr 2025

‘If they cut too much, people will die’: Health coalition pushes GOP on Medicaid funding

Tina Ewing-Wilson remembers the last time major Medicaid cuts slashed her budget.

3 Apr 2025

Trump’s DEI undoing undermines hard-won accommodations for disabled people

For years, White House press conferences included sign language interpreters for the deaf.

3 Apr 2025

Racial and age disparities in cervical artery dissection hospitalizations

Cervical artery dissection is a tear in an artery in the neck that provides blood flow to the brain. Such a tear can result in blood clots that cause stroke. A new study has found almost a five-fold increase in the number of U.S. hospitalizations for cervical artery dissection over a 15-year period.

3 Apr 2025

Machine learning models predict dementia risk among American Indian/Alaska Native adults

Machine learning algorithms utilizing electronic health records can effectively predict two-year dementia risk among American Indian/Alaska Native adults aged 65 years and older, according to a University of California, Irvine-led study.

2 Apr 2025

Survey reveals high rate of NHS-related harm in Great Britain

Almost one in ten people in Great Britain experienced healthcare-related harm due to care or treatment they received from the National Health Service (NHS) or difficulties accessing care in the last three years, show the findings of a large population survey published in the journal BMJ Quality & Safety.

2 Apr 2025

Vegetarian diets may hinder healthy aging—unless diet quality is high

Older Chinese adults who followed vegetarian diets were less likely to reach age 80 in good health. However, this disadvantage disappeared for those consuming high-quality plant-based diets.

2 Apr 2025

New insights into how disruption of calcium transport leads to autism and intellectual disability

A new study by McGill University researchers yields insights into how the disruption of calcium transport in the brain is linked to autism and intellectual disability.

2 Apr 2025

Scientists make breakthrough in understanding the causes of spina bifida

Scientists at Rady Children's Institute for Genomic Medicine, and the Department of Neurosciences and Pediatrics at the University of California, San Diego, have made a significant breakthrough in understanding the causes of spina bifida, a serious birth defect affecting thousands of newborns each year.

1 Apr 2025

Only 13% of French adults have optimal heart health—here’s what’s driving the gap

Only 13% of French adults aged 18–69 have optimal cardiovascular health, according to a national study using the American Heart Association’s Life’s Essential 8 (LE8) score. The findings highlight missed prevention opportunities and suggest that modest lifestyle changes could prevent up to 81% of cardiovascular events.

1 Apr 2025

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral semaglutide) significantly reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes and cardiovascular disease (CVD) and/or chronic kidney disease (CKD).

1 Apr 2025

New AI voice screening method improves detection of anxiety and depression

Scientists at the National Center for Supercomputing Applications and the University of Illinois College of Medicine Peoria (UICOMP) were authors of a research paper published in the Journal of Acoustical Society of America Express Letters that demonstrates improved, automated screening methods for anxiety and major depressive disorders.

31 Mar 2025

Heart Failure Center Certification aims to enhance patient outcomes worldwide

More than 56 million people globally live with heart failure (HF), which prevents the body from getting enough of the oxygen-rich blood it needs to work properly.

27 Mar 2025

Disability News and Research

New award to recognize contributions linking neuroscience to psychiatric diagnosis and treatment

Tolebrutinib shows promise for treating non-relapsing secondary progressive multiple sclerosis

Study reveals socioeconomic inequalities in unmet needs for mental health care across the EU

Mindfulness and CBT provide long-term relief for chronic back pain

Predicting treatment failure in cutaneous leishmaniasis with precision medicine

AI tool helps track treatment progress in multiple sclerosis patients

The House Speaker’s eyeing big cuts to Medicaid. In his Louisiana district, It’s a lifeline.

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

‘If they cut too much, people will die’: Health coalition pushes GOP on Medicaid funding

Trump’s DEI undoing undermines hard-won accommodations for disabled people

Racial and age disparities in cervical artery dissection hospitalizations

Machine learning models predict dementia risk among American Indian/Alaska Native adults

Survey reveals high rate of NHS-related harm in Great Britain

Vegetarian diets may hinder healthy aging—unless diet quality is high

New insights into how disruption of calcium transport leads to autism and intellectual disability

Scientists make breakthrough in understanding the causes of spina bifida

Only 13% of French adults have optimal heart health—here’s what’s driving the gap

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

New AI voice screening method improves detection of anxiety and depression

Heart Failure Center Certification aims to enhance patient outcomes worldwide

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News